Jake Jensen
Food and Drug Administration
3 Papers
Jake Jensen is an academic researcher from Food and Drug Administration. The author has contributed to research in topics: Cytotoxicity & Microbiome. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Exposure to Arsenite in CD-1 Mice during Juvenile and Adult Stages: Effects on Intestinal Microbiota and Gut-Associated Immune Status.
Kuppan Gokulan,Matthew Grant Arnold,Jake Jensen,Michelle Vanlandingham,Nathan C. Twaddle,Daniel R. Doerge,Carl E. Cerniglia,Sangeeta Khare +7 more
TL;DR: Results of this study highlight significant changes in the intestinal microbiome and gut-associated immune status during a single or repeated exposure to arsenic in juvenile and adult animals.
67
In vitro inflammation and toxicity assessment of pre- and post-incinerated organomodified nanoclays to macrophages using high-throughput screening approaches
Todd A. Stueckle,Jake Jensen,Jayme P Coyle,Raymond C. Derk,Alixandra Wagner,Cerasela Zoica Dinu,Tiffany G. Kornberg,Sherri A Friend,Alan Dozier,Sushant Agarwal,Rakesh K Gupta,Liying W. Rojanasakul +11 more
TL;DR: This study investigates the in vitro inflammatory and cytotoxic effects of pre- and post-incinerated organomodified nanoclays on human macrophages, revealing that organic coating and incineration status influence inflammatory and cytotoxic responses, with incineration abating cytotoxic effects.
Variation in pentose phosphate pathway-associated metabolism dictates cytotoxicity outcomes determined by tetrazolium reduction assays
Jayme P Coyle,C. Johnson,Jake Jensen,Mariana T. Farcas,Raymond C. Derk,Todd A. Stueckle,Tiffany G. Kornberg,Yon Rojanasakul,Liying W. Rojanasakul +8 more
TL;DR: In this paper , the authors demonstrate how interpretation of results from several standard cytotoxicity and proliferation assays vary in dependence on contributions from the pentose phosphate pathway (PPP), and decouple "mitochondrial activity" as an interpretation of cellular formazan and Alamar Blue metabolism.